207_Combined course Presentations
FUTURE DIRECTION: combination of molecular signatures with new drugs
IDH mutant tumor cells are sensitive to PARP inhibitors
Sulkowski PL. et al. Sci Transl. Med. 2017;9
Made with FlippingBook
FUTURE DIRECTION: combination of molecular signatures with new drugs
IDH mutant tumor cells are sensitive to PARP inhibitors
Sulkowski PL. et al. Sci Transl. Med. 2017;9
Made with FlippingBook